NCT04866641 2025-05-30
Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors
Taivex Therapeutics Corporation
Phase 1 Recruiting
Clinical Trials
12 trialsNCT04275960 2020-12-29
Study in Healthy Adult Male Participants to Gather Information How the Human Body Absorbs, Distributes and Excretes the Study Drug Selitrectinib Including the Effect of the Interaction of Food With the Study Drug on the Human Body
Bayer
Phase 1 Completed
NCT00555724 2017-01-09
Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors
Biogen
Phase 1 Completed
NCT01515969 2016-07-12
Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)
Stanford University
Phase 1 Terminated
NCT00956436 2013-09-16
Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)
Biogen
Phase 1 Completed
NCT00970580 2013-09-16
A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer
Biogen
Phase 1 Completed
NCT00633724 2013-08-15
Multiple-Vaccine Therapy in Treating Patients With Non-small Cell Lung Cancer
Fukushima Medical University
Phase 1 Completed
NCT00874588 2013-08-15
Peptide Vaccine Targeting to Cancer Specific Antigen Combined With Anti-angiogenic Peptide Antigen in Treating Patients With Non-small Cell Lung Cancer
Fukushima Medical University
Phase 1 Completed
NCT00632333 2011-07-21
Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer
Teikyo University
Phase 1 Unknown
NCT01266707 2010-12-24
Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma
Fukushima Medical University
Phase 1 Unknown
NCT01266720 2010-12-24
HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1)
Fukushima Medical University
Phase 1 Unknown
NCT00561275 2008-07-15
Safety Study of Multiple Peptide Vaccine to Esophageal Cancer
Japanese Foundation for Cancer Research
Phase 1 Completed